Clinical and Laboratory Parameters Associated with Septic Myocardial Dysfunction in Children with Septic Shock

Samriti Gupta1, Jhuma Sankar2, Praveen Narsaria1

  • 1Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India.

Insights

In children with septic shock, prolonged capillary refill time, elevated lactate, low platelets, and increased blood urea may indicate septic myocardial dysfunction (SMD). Early cardiac function assessment is recommended for these pediatric patients.

Area of Science:

  • Pediatric critical care medicine
  • Cardiology
  • Infectious diseases

Background:

  • Septic shock in children can lead to myocardial dysfunction.
  • Early identification of septic myocardial dysfunction (SMD) is crucial for improving outcomes.
  • Clinical and laboratory parameters at admission may predict SMD.

Purpose of the Study:

  • To identify clinical and laboratory parameters associated with septic myocardial dysfunction (SMD) in children with septic shock.
  • To determine predictors of SMD in pediatric patients.
  • To assess the relationship between admission parameters and cardiac function in pediatric septic shock.

Main Methods:

  • Retrospective chart review of pediatric patients (3 months to 17 years) with fluid-refractory septic shock.
  • Echocardiography performed within 3 hours of admission to diagnose septic myocardial dysfunction (SMD).
  • Univariate and multivariate analyses to identify associated factors.

Main Results:

  • Of 95 children, 46% (44) had septic myocardial dysfunction (SMD).
  • Children with SMD showed longer capillary refill time (CRT), increased lactate, lower platelet count, increased blood urea, and elevated alanine aminotransferase (ALT).
  • Multivariate analysis did not find these parameters to be significant predictors; however, mortality was higher in children with SMD (36% vs. 20%).

Conclusions:

  • Prolonged CRT, elevated lactate, low platelets, increased blood urea, and high liver enzymes may be associated with SMD in pediatric septic shock.
  • These findings suggest a potential need for early cardiac function assessment in children presenting with these parameters.
  • Further research is needed to validate these associations and their impact on mortality.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
99
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
530
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
89
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
220
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
331
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
70